Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment

American Journal of Ophthalmology - Tập 224 - Trang 282-291 - 2021
David Braun1,2,3, Darios Getahun1,2, Vicki Y. Chiu1, Anne L. Coleman4,5, Gary N. Holland4, Fei Yu4,5, Lynn K. Gordon4, Michel M. Sun4
1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA
2Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA
3Department of Pediatrics, Kaiser Permanente Panorama City, Panorama City, California, USA
4UCLA Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
5Jonathan and Karin Fielding School of Public Health, UCLA, Los Angeles, California, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

American Journal of Ophthalmology

Tập 224

282-291

Thông tin tác giả